{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967805",
  "id": "02967805",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1348",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06lmyw391hd9t2.pdf",
  "summary": "- **Capital Raising Type**: Placement to a director (Dr Gabriel Liberatore) under SPP terms  \n- **Securities Issued**:  \n  - **Ordinary Shares (OSL)**: 17,271 shares at **AUD 1.158/share**  \n  - **Attaching Options**: 17,271 options (new class), exercisable at **AUD 1.20** expiring **31-Jul-2027**  \n- **Approval**: Shareholder approval obtained at EGM on **8-Jul-2025**  \n- **Issue Date**: **8-Aug-2025**  \n- **Use of Proceeds**: Clinical trials, administration, working capital",
  "usage": {
    "prompt_tokens": 2175,
    "completion_tokens": 144,
    "total_tokens": 2319,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T05:55:21.540793"
}